King patent opposition analysis

The comprehensive analysis of King opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by King

Patent NumberTitleApplicantOpposition DateOpposition Company
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 28, 2026SANDOZ
Connectors For Making Connections Between Analyte Sensors And Other DevicesABBOTTApr 16, 2026ELKINGTON AND FIFE
Absorbent Article With Improved Elastic PanelsONTEXApr 16, 2026THE PROCTER & GAMBLE
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 13, 2026ELKINGTON AND FIFE
Methods Of Treating Estrogen Receptor-Associated DiseasesOLEMA PHARMACEUTICALSApr 9, 2026GENERICS UK
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIMApr 2, 2026TEVA PHARMACEUTICALS
Compositions And Methods For The Treatment Of Graft Versus Host DiseaseVECTIVBIOApr 2, 2026TEVA PHARMACEUTICALS
New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIMApr 2, 2026TEVA PHARMACEUTICALS
Control Arrangement For A Hydraulic Three-Point Power LiftDEEREMar 27, 2026AGCO
Control Arrangement For A Hydraulic Three-Point Power LiftDEEREMar 27, 2026AGCO